Litcius/Paper detail

Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study

David C Qian, Troy Kleber, Brianna Brammer, Karen M Xu, Jeffrey M Switchenko, James R Janopaul-Naylor, Jim Zhong, Melinda L Yushak, R Donald Harvey, Chrystal M Paulos, David H Lawson, Mohammad K Khan, Ragini R Kudchadkar, Zachary S Buchwald

2021The Lancet Oncology193 citationsDOI

Topics & Concepts

MedicinePropensity score matchingOncologyInternal medicineOverall survivalImmunotherapyMelanomaLongitudinal studyRadiation therapySurvival analysisCancerRadiation oncologyMEDLINEClinical trialMetastatic melanomaTranslational researchSurvival rateCancer immunotherapyIpilimumabChemotherapyCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementImmunotherapy and Immune Responses
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study | Litcius